Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huang, M.-T.
Right arrow Articles by Conney, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, M.-T.
Right arrow Articles by Conney, A. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press

research-article

Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells

Mou-Tuan Huang, Wei Ma, Patricia Yen, Jian-Guo Xie, Jingkang Han 1, Krystyna Frenkel 1, Dezider Grunberger 2 and Allan H. Conney 3

Laboratory for Cancer Research, Department of Chemical Biology, College of Pharmacy, Rutgers, The State University of New Jersey Piscataway, NJ 08855-0789.
1Department of Environmental Medicine, New York University Medical Center New York, NY 10016-6451
2Institute of Cancer Research, College of Physicians and Surgeons, Columbia University New York, NY 10032, USA

3To whom reprint requests should be sent

Topical application of caffeic acid phenethyl ester (CAPE), a constituent of the propolis of honeybee hives, to the backs of CD-1 mice previously initiated with 7, 12-dimethylbenz[{alpha}]anthracene (DMBA) inhibited 12-O-tetra-decanoylphorbol-13-acetate (TPA)-induced tumor promotion and the formation of 5-hydroxymethyl-2'-deoxyuridine (HMdU) in epidermal DNA. Topical application of 5 nmol TPA twice weekly for 20 weeks to mice previously initiated with 200 nmol ofDMBA resulted in 18.8 skin papillomas per mouse. Topical application of 1, 10, 100 or 3000 nmol of CAPE together with 5 nmol of TPA twice a week for 20 weeks inhibited the number of skin papillomas per mouse by 24, 30, 45 or 70%, respectively, and tumor size per mouse was decreased by 42, 66, 53 or 74%, respectively. Topical application of 5 nmol of TPA twice weekly for 20 weeks to mice previously initiated with DMBA produced an average of 12.6 HMdU residues per 104 normal bases in epidermal DNA. Topical application of 1, 10, 100 or 3000 nmol of CAPE with 5 nmol of TPA twice weekly for 20 weeks to DMBA-initiated mice decreased the level of HMdU in epidermal DNA by 40-93%. The in vitro addition of 1.25, 2.5, 5, 10 or 20 µM CAPE to cultured HeLa cells inhibited the synthesis of DNA by 32, 44, 66, 79 or 95%, respectively, the synthesis of RNA was inhibited by 39, 43, 58, 64 or 75%, respectively, and the synthesis of protein was inhibited by 29, 30, 37, 32 or 47%, respectively. The results indicate a potent inhibitory effect of CAPE on TPA-induced tumor promotion and TPA-induced formation of HMdU in DNA of mouse skin as well as an inhibitory effect of CAPE on the synthesis of DNA, RNA and protein in cultured HeLa cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
M. C. Bufalo, J. M. G. Candeias, and J. M. Sforcin
In vitro Cytotoxic Effect of Brazilian Green Propolis on Human Laryngeal Epidermoid Carcinoma (HEp-2) Cells
Evid. Based Complement. Altern. Med., December 1, 2009; 6(4): 483 - 487.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C.-C. Ho, S.-S. Lin, M.-Y. Chou, F.-L. Chen, C.-C. Hu, C.-S. Chen, G.-Y. Lu, and C.-C. Yang
Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo
J. Antimicrob. Chemother., August 1, 2005; 56(2): 372 - 379.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Marquez, R. Sancho, A. Macho, M. A. Calzado, B. L. Fiebich, and E. Munoz
Caffeic Acid Phenethyl Ester Inhibits T-Cell Activation by Targeting Both Nuclear Factor of Activated T-Cells and NF-{kappa}B Transcription Factors
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Scapagnini, R. Foresti, V. Calabrese, A. M. G. Stella, C. J. Green, and R. Motterlini
Caffeic Acid Phenethyl Ester and Curcumin: A Novel Class of Heme Oxygenase-1 Inducers
Mol. Pharmacol., March 1, 2002; 61(3): 554 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. R. Fitzpatrick, J. Wang, and T. Le
Caffeic Acid Phenethyl Ester, an Inhibitor of Nuclear Factor-kappa B, Attenuates Bacterial Peptidoglycan Polysaccharide-Induced Colitis in Rats
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 915 - 920.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. N. Mahmoud, A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli
Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis
Carcinogenesis, May 1, 2000; 21(5): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Michaluart, J. L. Masferrer, A. M. Carothers, K. Subbaramaiah, B. S. Zweifel, C. Koboldt, J. R. Mestre, D. Grunberger, P. G. Sacks, T. Tanabe, et al.
Inhibitory Effects of Caffeic Acid Phenethyl Ester on the Activity and Expression of Cyclooxygenase-2 in Human Oral Epithelial Cells and in a Rat Model of Inflammation
Cancer Res., May 1, 1999; 59(10): 2347 - 2352.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.